Savvy Updates, 10/31/22: Dexcom Profit Surges, New Islet Cell Transplant Method, Almonds and Gut Microbiome, Breath Vapors Algorithm into BG Readings
Dexcom Q3 profit surges as CGM maker prepares for G7 launch in U.S. was reported by Elise Reuter for MedTechDive.com, 28 October 2022. The company expects to begin selling its newest continuous glucose monitor in the first quarter of 2023 if it receives FDA...
Savvy Updates, 10/24/22: Omnipod DASH PDM Recall, Insulin Rationing in the US (SHAMEFUL!), Wearable Tech to Charge Devices
Insulet flags battery problem with Omnipod DASH system was posted by Elise Reuter for MedTechDive.com, 17 October 2022. Insulet issued an urgent medical device correction, on 17 October 2022, related to battery problems with a component of its Omnipod...
Savvy Updates, 10/17/22: Dexcom G7 Global Rollout, T2D Drugs Help T1Ds, BefA Gut Bacteria & Beta Cell Production, FDA TAP Pilot Program for New D Devices
Dexcom Announces Global Rollout of G7, as reported by Andrew Briskin for diaTribe.org, 10 October 2022. Dexcom, one of the leading manufacturers of CGM, announced on Oct. 4 that its latest product, the Dexcom G7, is now available for people with diabetes, ages 2...
Savvy Updates, 10/10/22: Indigo Continuous Multi-Metabolite (CMM) Sensor, T1D More Difficult/Dangerous for Girls
Indigo Diabetes enrolls first subject in multi-metabolite sensor trial was published by MedicalDevice-Network.com, 30 September 2022. Belgian diabetes device company Indigo Diabetes has enrolled the first participant in the Shine (multi-center, open-label,...
Savvy Updates, 10/3/22: EASD 2022 Highlights, Diabetes Product Waste, All About Fat, Bolusing for Fats & Proteins
Highlights From EASD 2022 was written by Andrew Briskin, Arvind Sommi and Natalie Sainz for diaTribe.org, 21 September 2022. Here’s a great overview of presentations at this year’s EASD (European Association for the Study of Diabetes) Annual Meeting, held...
More Diabetes Blogs